The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mulligan Seamus since 2015.
This trader's CIK number is 1536639.
At the time of last reporting, Mulligan Seamus was the Director of Jazz Pharmaceuticals Plc. (stock ticker symbol JAZZ).
Also see all insider trading activities at Jazz Pharmaceuticals Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | JAZZ | 0 | $0 | 0 | $0 | 3,415 | $471,543 |
| 2025 | JAZZ | 101,621 | $10,057,861 | 0 | $0 | 0 | $0 |
| 2023 | JAZZ | 0 | $0 | 0 | $0 | 4,500 | $266,085 |
| 2020 | JAZZ | 50,000 | $5,544,330 | 0 | $0 | 0 | $0 |
| 2018 | JAZZ | 50,000 | $7,179,700 | 0 | $0 | 0 | $0 |
| 2016 | JAZZ | 0 | $0 | 83,904 | $11,219,082 | 0 | $0 |
| 2015 | JAZZ | 0 | $0 | 127,968 | $22,155,736 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-05-28 | JAZZ | Option Ex | 3,415 | 138.08 | 471,543 |
| 2025-05-09 | JAZZ | Buy | 100,000 | 98.91 | 9,890,900 |
| 2025-05-12 | JAZZ | Buy | 1,621 | 103.00 | 166,961 |
| 2023-03-04 | JAZZ | Option Ex | 4,500 | 59.13 | 266,085 |
| 2020-05-27 | JAZZ | Buy | 35,000 | 110.99 | 3,884,580 |
| 2020-05-26 | JAZZ | Buy | 15,000 | 110.65 | 1,659,750 |
| 2018-11-15 | JAZZ | Buy | 50,000 | 143.59 | 7,179,700 |
| 2016-08-25 | JAZZ | Sale | 27,968 | 128.19 | 3,585,078 |
| 2016-05-24 | JAZZ | Sale | 27,968 | 150.13 | 4,198,807 |
| 2016-02-23 | JAZZ | Sale | 27,968 | 122.83 | 3,435,197 |
| 2015-11-20 | JAZZ | Sale | 17,725 | 145.70 | 2,582,567 |
| 2015-11-23 | JAZZ | Sale | 10,243 | 147.65 | 1,512,419 |
| 2015-03-25 | JAZZ | Sale | 50,000 | 176.22 | 8,810,750 |
| 2015-03-18 | JAZZ | Sale | 50,000 | 185.00 | 9,250,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mulligan Seamus (Director of Jazz Pharmaceuticals Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.